Cipher Pharmaceuticals Inc.CPH.TO

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · cipherpharma.com

Cipher Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company that acquires, develops, and commercializes novel formulations of existing drugs, with a focus on dermatology. Its lead products are Epuris (isotretinoin), the leading branded acne treatment in Canada, and Natroba (spinosad), a head-lice and scabies topical it sells directly in the U.S. following the 2024 ParaPRO acquisition, alongside a portfolio of licensed Canadian products and out-licensing income. Headquartered in Mississauga, Ontario, Cipher reports in U.S. dollars, is debt-free, and trades on the TSX (CPH) and OTCQX (CPHRF).

Key ratios

Operating cash flow growth

28.1%TTM

2025 52.1%2024 22.2%2023 49.2%

EPS growth

140.8%TTM

2025 128.3%2024 -42.5%2023 -22.3%

FCF / Sales

54.4%TTM

2025 58.9%2024 -181.3%2023 74.9%

Net margin

58.4%TTM

2025 54.2%2024 34.6%2023 96.3%

ROA

7.9%TTM

2025 6.6%2024 4.0%2023 8.1%

ROE

23.5%TTM

2025 23.9%2024 12.6%2023 28.2%

Revenue growth

4.3%TTM

2025 51.2%2024 57.7%2023 2.4%

Recent news

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award 2026-09-01 · CNW Cipher Pharmaceuticals Reports Second Quarter 2026 Results 2026-08-11 · CNW Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call 2026-07-31 · CNW Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris 2026-07-06 · Newswire (CNW)Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders 2026-06-18 · CNW (Canada Newswire)Cipher Pharmaceuticals Reports First Quarter 2026 Results 2026-05-07 · CNW (Canada Newswire)Cipher Pharmaceuticals Announces Normal Course Issuer Bid 2026-05-01 · CNW (Canada Newswire)Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call 2026-04-29 · CNW (Canada Newswire)Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings 2026-03-12 · CNW (Canada Newswire)

Track CPH.TO in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer